HomeVXL • CVE
add
Vaxil Bio Ltd
Previous close
$0.010
Year range
$0.010 - $0.035
Market cap
1.37M CAD
Avg Volume
52.93K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 33.00K | -76.26% |
Net income | -28.00K | 79.86% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -32.50K | 76.62% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.01M | -40.12% |
Total assets | 1.05M | -38.92% |
Total liabilities | 190.00K | -54.44% |
Total equity | 860.00K | — |
Shares outstanding | 136.98M | — |
Price to book | 1.00 | — |
Return on assets | -7.60% | — |
Return on capital | -9.44% | — |
Cash Flow
Net change in cash
(CAD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -28.00K | 79.86% |
Cash from operations | -49.00K | 68.59% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -55.00K | 65.41% |
Free cash flow | -40.62K | 60.89% |
About
Founded
2006
Headquarters
Website